Objective: Over a 4-year period in Toronto, this study aimed to compare individuals on a community treatment order (CTO) with individuals not on a CTO in terms of sociodemographic and clinical variables, hospital use, and continued engagement with health services on exit from the case management program. Hospital stay reductions from preadmission into the program to various postadmission periods were compared across the 2 groups.
I n December 2000, the province of Ontario proclaimed amendments to its Mental Health Act, broadening the criteria for involuntary hospitalization and providing for the issuance of CTOs.
In Ontario, CTOs provide community-based treatment and support to persons with serious mental disorder associated with recurrent hospitalization and deterioration in the community. CTOs prescribe a set of treatment conditions customized to the person, based on the consent of the individual or his or her SDM. Failure to adhere to the treatment plan may trigger apprehension by the police and return to hospital for psychiatric evaluation. CTOs are valid for up to 6 months, may be cancelled at any time, and may be renewed. CTOs are considered treatment under the Health Care Consent Act. The person who is subject to a CTO, or his or her SDM, can appeal its application to a tribunal. For more information on CTO criteria, see Section 33.1 of the Mental Health Act 1990. 1 As Dawson noted in his international study, CTOs in Ontario raised questions of ethical and constitutional significance. 2 Specifically, opponents of mandated treatment stated fears that community support would be replaced with increased focus on control, with compulsion used as an alternative to intensive case management or ACT when the latter may be all that is required. 3, 4 Nonetheless, the Ontario legislation was passed in the belief that some restrictions on liberty were outweighed by the benefits of providing mandated care in the community to individuals experiencing serious mental illness and frequent hospitalizations. The intent in the legislation was to provide a less restrictive environment than involuntary detention in hospital. Many clinicians experienced in using CTOs also report they are effective in enabling stability in people with severe mental illness. 5 CTOs are used in many jurisdictions in the developed world, including Australia, New Zealand, the United Kingdom, and the United States. 6 In Toronto, CAMH (the principal teaching hospital for psychiatry and addictions at the University of Toronto) was given the responsibility to coordinate hospital-based referrals of patients eligible for CTOs. The Toronto branch of CMHA, Toronto's largest community-based mental health services provider, was responsible for providing intensive case management to outpatients on CTOs. Both organizations worked together to implement, manage, and monitor CTO services in Toronto.
Lawton-Smith 7 has found the population-based use rates for CTOs range from 2/100 000 to over 40/100 000 in various countries. After 4 years in Ontario, a province with a population of 11 410 046, the use rates appear to be 17/100 000 in the population. 8 9 Given an estimated 1% prevalence rate of schizophrenia, these use rates indicate that less than 2% of people with schizophrenia in Toronto have been placed on CTOs since 2001.
The current retrospective study seeks to describe the Toronto experience with CTOs to date as well as to explore some of the preliminary outcomes for individuals served through the CMHA CTO Case Management Program, compared with individuals receiving similar CMHA intensive case management services in the absence of a CTO.
CTO Research Literature
Research on coercive intervention in psychiatry faces numerous methodological and ethical challenges. 10 The research literature on CTOs in the United States, Australia, and New Zealand is extensive and will not be summarized here, with the exception of a few major themes. Smaller naturalistic studies of CTOs have been reported from Quebec and Ontario. 11, 12 A comprehensive review of the evidence was conducted by the Rand Corporation 13 ; it emphasized the lack of strong empirical evidence for CTOs despite their availability in most US jurisdictions. Other more recent studies, mostly matched control studies and reviews, have also offered mixed results on the effectiveness of CTOs. Some studies have shown CTOs do not reduce the risk of hospital admissions, while other studies have shown similar reduction in hospitalizations between CTO clients and control groups. 6, [14] [15] [16] [17] In addition, the literature also identifies the impact of CTOs on engagement with treatment services. There is evidence to suggest CTOs may improve compliance with treatment during the CTO, enhance use of community support and health services during and after the CTO, and positively affect the behaviour of service providers. 18, 19 However, a review of the literature still does not clarify whether it is the compulsory nature of the CTO or the commitment of assertive community services that influences positive results for individuals.
In contemporary psychiatric research on treatment interventions, the gold standard of methodology is the RCT. Application of this method to legalized coercive intervention in the community is fraught with difficulty. It is not surprising, therefore, that among the plethora of treatment studies involving CTOs, only 2 RCTs have been conducted, each with its own methodological limitations. 20, 21 These 2 studies have recently been subject to rigorous metaanalysis. 6 The conclusion of that review is that CTOs may not be an effective alternative to standard care and that no evidence exists across the 2 studies of differential benefit to CTOs with regard to costeffectiveness, service use, social functioning, or quality of life. It further raised concern about the imbalance between the intrusion on civil liberties in the community and the likelihood of this resulting in clinical benefit to any one individual. However, the methodological rigour in this metaanalysis led to exclusion of the vast majority of outcome studies of CTOs because they were not RCTs; a subsequent metaanalysis of randomized and nonrandomized evidence across 5 studies provided extremely limited support for CTOs reducing either number or duration of hospitalizations. 22 Indeed, virtually all scientific papers reporting outcomes of CTO implementation have been either mirror-image or pre-post studies, where individuals serve as their own controls. These are cohort studies and are an accepted research methodology, although they carry significant limitations in interpretation with regard to natural history in the absence of the intervention and other factors.
One of the largest cohort studies reported to date on CTOs emanates from New York State, where a 5-year report on the clinical impact of the related legislation was recently published. 23 While this report does not report the statistical significance of its findings, the changes reported among individuals subject to CTOs are nevertheless clinically striking. There were increases across several relevant clinical domains subsequent to CTO implementation, including engagement with treatment services, adherence to medication, and self-care-activities of daily living. There were also decreases in the following: substance abuse; assaultive, antisocial, and self-harm behaviour; hospitalization rates and cumulative days in hospital per hospital admission; and homelessness, arrest, and incarceration.
Despite the number of subjects and the numerous outcome measures reported in this study, subjects acted as their own controls and it is not known how these outcomes would compare to outcomes for similar individuals receiving intensive case management in the absence of a CTO. 5 In addition, this type of study design is weakened by the possibility of temporal changes in hospitalization rates, such as the progressive reduction of hospital beds. 5 Possibly the greatest threat to internal validity of this type of design is the influence of regression toward the mean where individuals are subjected to the CTO precisely because they are at the nadir of their functioning and have extremely high hospitalization days; simply based on probability, their hospitalizations are likely to shift downward toward the population mean. 24, 5 Despite the methodological limitations, it is essential that service providers carefully scrutinize the impact of their use of CTOs across a broad range of outcomes from service use and cost to client and family satisfaction, perceived coercion, and quality of life. A modification to cohort studies involves the use of a clinically similar comparison group of individuals with severe and persistent mental illness who are not subject to a CTO but who otherwise receive similar clinical services. Although this design is inferior to an RCT precisely because of the lack of randomization, it does address some of the above-mentioned threats to internal validity and provides some useful comparisons.
Study Design
The current study follows a cohort (pretest, posttest) study design with a nonequivalent comparison group. We explore the evidence for CTO use in Toronto by examining outcomes for individuals on a CTO compared with a group of individuals not on a CTO. The 2 groups both received similar intensity of services from the same service organization (CMHA) on discharge from hospital, except the comparison group had not been issued a CTO.
Similar Intensity of Care
Recent literature has highlighted the need for studies that differentiate between whether it is the intensity of service or the compulsory nature of the services that affect client outcomes. 6 Although the current study is not an RCT, the CMHA Toronto community mental health program had a unique opportunity to explore this question because it offered the same services through one group of case managers to individuals subject to CTOs and to another group of individuals who were similar to the CTO group, except that they were not on CTOs. Because the intensity of the services was the same for both the CTO group and the non-CTO group, this study can offer some insight into the impact of the compulsory nature of CTOs on client outcomes.
The data reported on cover the period from April 2001 to March 2005. life for individuals experiencing serious and persistent mental illness. The caseload ratio is about 1 to 15. The services are client-centred, focusing on choice and skill building and enhancement. Principles of recovery, psychiatric rehabilitation, choice, and empowerment are emphasized.
The clients served are individuals with severe and persistent mental illness who have either been issued a CTO (and thus meet specific criteria as outlined in the legislation) or have been identified as individuals who have traditionally not engaged with services, would benefit from case management services, and are similar to the CTO group in terms of demographic information (the non-CTO group). None of the clients in either group served had received case management services for at least 1 year prior to admission into the program and most had never received intensive case management before. Both groups began receiving case management services once discharged from an inpatient psychiatric facility, within one week of referral to the case management program. For the CTO group, initiation of the CTO and case management services occurred simultaneously.
CMHA provided case management to 224 clients on CTOs and began accepting individuals into the program in May 2001. Most individuals were subject to only one CTO. The program also accepted individuals who had not been issued a CTO. This group formed our comparison group. Ninety-two non-CTO clients received case management services.
Hypotheses
In this study, the following hypotheses guided our research questions: we hypothesized that, given similar entrance criteria and that both groups were receiving similar services, there would be no significant differences in sociodemographic variables; we hypothesized there would be no significant differences in hospital use between the 2 groups; and we hypothesized that individuals on a CTO would be less likely to stay engaged in treatment on a voluntary basis once the CTO expired or was cancelled.
Methods
Descriptive statistics and tests of statistical significance were run on regularly collected administrative data for both groups. Exploratory data analysis was conducted and missing data were cross referenced with paper versions of client files to ensure accuracy and completeness of data. Because this was not an RCT, the possibility that selection bias might account for some difference in hospital outcomes between the 2 groups could not be excluded. To minimize this threat and the influence of extraneous variables, the 2 groups were compared on several sociodemographic, clinical, and health service use variables commonly compared in CTO studies. We conducted chi-square tests across all these sociodemographic variables (P < 0.05), using SPSS software (SPSS Inc, Chicago, IL).
Reductions in the number of hospital admissions were calculated for the 2 groups by subtracting the number of hospital admissions in the 6-month and the 6-to 12-month follow-up periods after initiation of services from the number of hospital admissions in the 6 months prior to the initiation of service. Reduction of cumulative days in hospital (measured in days) was calculated in the same way. Independent sample t tests were conducted with SPSS to compare the reduction in hospital admissions between CTO and non-CTO groups and the reduction in cumulative days in hospital, again between the 2 groups.
Results

How did the CTO population compare with the non-CTO population on admission to the program?
Sociodemographic variables included age, sex, language, ethnicity, education, housing status, and with whom the subject was living. Clinical variables included diagnosis. Health service variables included the number of hospital admissions and cumulative days in hospital per admission for the 6-month period prior to the initiation of intervention.
There were no significant differences in clinical variables between the 2 groups. Most clients in both groups had a primary diagnosis of schizophrenia, and both groups had a minority of clients with a primary diagnosis of mood disorder ( Table 1 ). All sociodemographic variables across the 2 groups were similar, except for the 2 housing variables on admission. On admission, a significantly higher percentage of CTO clients lived with family members in privately owned residences, compared with the non-CTO group, which had a larger proportion of clients living with nonfamily persons, for example, in boarding homes.
Although both groups demonstrated high numbers of hospital admissions and a large number of hospital days per hospitalization preadmission to CMHA services, the CTO group had statistically higher means for both these health service use variables.
Were there significant differences in hospital use between the CTO and non-CTO groups after the first CTO (6-month) period and after the second 6-month period?
There was a reduction in the number of hospital admissions when the 6-month period prior to initiation of CTO or non-CTO case management services was compared with both the 6-month and the 6-to 12-month follow-up periods after initiation of services for the 2 groups ( Table 2 ). The reduction recorded for the second 6-month period was statistically greater for the CTO group. Interestingly, it is worth noting that all hospital admissions for the CTO and non-CTO groups were involuntary for the 6-month and 6 to 12 month follow up periods after initiation of the case management services.
There was also a clinically significant reduction in duration of the length of hospitalizations when the period prior to initiation of CTO or non-CTO case management services was compared with the 2 post periods (6 months or less, 6 to 12 months). However, statistical analysis revealed that the reduction in the CTO group was significantly higher than in the non-CTO group.
Was there a difference in continued engagement with services after CTO expiry for the CTO group and on exit from the program between the 2 groups?
The average length of stay with case management services for the CTO group was 422.7 days (median 306 days) with a range of 23 to 1401 days. Figures for the non-CTO group indicate an average stay of 519.5 days (median 519.5 days) with a range of 20 to 1235 days. The 2 groups did differ statistically on their length of stay in case management. Most CTO clients received services for a year or less and most non-CTO clients stayed within the program for longer than a year (Table 3) . For all CTO clients, case management services were a condition of the CTO; about 38% of individuals on a CTO had their CTO renewed, meaning most clients did not receive a second CTO. It is clinically significant to note that 64.2% of CTO clients remained engaged with case management services for some period of time once their CTO had expired (Table 4 ).
Among those leaving either program, there were differences in exit disposition for clients who were with the programs for at least 6 months or more that did not reach statistical significance but were of clinical interest. Of the CTO clients, 27.7% exited with referral and linkage to formal community support (such as case management or ACT services), compared with 51.2% of the non-CTO group. A further 39.4% of CTO clients exited with ongoing medical supervision (psychiatrist, family physician, or other physical health care services), while only 25.6% of the non-CTO group exited with only ongoing medical supervision and were more likely to exit with formal community supports such as case management and ACT.
Most discharges from case management services were planned.
Discussion
This naturalistic study of CTO use and outcomes in Toronto-Canada's most populous city-represents the largest reported data set in Canada to date in this area. The comparisons between the CTO group and the non-CTO group were aided by the reality that both groups received intensive case management, minimizing the role of that service delivery variable in explaining the observed differences. Nevertheless, baseline differences were found in this nonrandom group assignment, and these are acknowledged below. It is beyond the ability of this paper to determine the individual clinical reasons for which people were placed on a CTO or not prior to entry into intensive case management. This issue requires further investigation. Variables might include degree of insight, previous nonadherence to treatment, or refusal to agree to voluntary treatment and follow-up at the time of referral.
Benefits of being on a CTO in terms of reduction in the number of hospital admissions were seen 6 to 12 months after initiation of the first CTO and the start of case management services. These calculations were for the entire CTO group (individuals on a current CTO and those whose CTO had expired but were still receiving case management services). This may suggest that reductions in hospital admissions can be seen once an individual has become stable on a CTO and that these reductions endure past the expiry of the CTO itself if supports are continued for the individual. Reductions in cumulative days in hospital per admission to hospital were seen throughout the period in which a CTO was in force.
The fact that the CTO group had significantly higher durations of hospitalization prior to the CTO implementation likely contributed to the greater reduction of hospitalization post-CTO implementation, and we cannot exclude the possibility that the CTO group scores might have been regressing to the mean. Nonetheless, although the CTO group had significantly higher reductions, both groups did experience clinically meaningful reductions. This does not allow us to draw any conclusions about the benefits of the compulsory nature of CTOs; however, our clinical experience as a community service agency suggests that CTOs may be helpful in facilitating client engagement with case management services and more responsiveness from the wider treatment support network.
The study's finding that most CTO clients are engaged in services for less than a year while most non-CTO clients are engaged for more than a year is in line with our hypothesis that individuals on CTOs are less likely to continue to engage with formal treatment, given the compulsory elements of the CTO. It may suggest a subgroup of CTO clients who are more likely to disengage from treatment when they have a choice to do so. Conversely, there is also evidence for another group of CTO clients who do continue to engage in formal community support of their own choice. Of clients whose CTO expired, 64% remained voluntarily with case management for some period after the CTO expiry. An additional 8% were transitioned to other case management or ACT services at expiry of the CTO (Table 4 ). This indicates that 72% of CTO clients remained engaged in services voluntarily for some period of time post-CTO, while only 22% were discharged at or before CTO expiry without continuation of services. A surprising finding was that the percentage of clients refusing services (Table 5) was the same for both groups. The finding that almost three-quarters of CTO clients remained engaged voluntarily with some sort of services post-CTO is clinically very encouraging in view of the clinical reality that CTOs are generally used for people when previous attempts at voluntary engagement in community services have been unsuccessful. The fact that CTO clients were more likely to remain connected with medical supervision following the expiry of the CTO raises interesting questions about the effect of the CTO on the physician-patient relationship. Do clients stay with medical supervision because the CTO has helped them learn to manage their medications or because the CTO actually helps build a more consistent relationship with the physician? This area should be explored further, along with the differences and similarities in relationships with case managers.
One limitation of this study is the large difference in sample size between the 2 groups. As a community mental health agency, we were mandated to provide priority case management services to clients subject to a CTO. As a result, we had to provide case management services to more CTO clients than non-CTO clients.
Because individuals in this study were not randomized into the CTO or non-CTO groups, selection bias is a threat to internal validity of the study. Because we used natural groups, we were not able to match individuals within the CTO group with similar individuals within the comparison group. We did, however, attempt to minimize selection bias by comparing the 2 groups across several sociodemographic and clinical variables. Although the 2 groups were similar across nearly all these variables, it is possible the 2 groups differed on variables not compared in our study.
Given that both groups had high hospitalization durations prior to entry into the CTO and non-CTO groups, regression to the mean cannot be ruled out and is an important element we have considered in the interpretation of our results. It is worth noting, however, that regression to the mean and selection bias are less important threats when the groups compared are natural groups who are both seeking services and have similar eligibility criteria. 24 How should CTO effectiveness be measured, given the methodological, clinical, and ethical challenges to optimal study design? We believe the operational measures of outcome need to be broadened. Some individuals may have the same number of hospitalizations but a reduction in the use of emergency services. Further, hospitalizations should also be identified as either voluntary or involuntary. Voluntary hospitalizations might reflect crisis prevention and a proactive approach to stabilization by planned, short-stay admissions. Symptom levels may provide better reflection of disease status than hospitalization, which can also be influenced by bed availability factors. Given the compulsory nature of CTOs, positive outcomes are not just reduction in hospital stays but increased engagement in other support services. 19 Currently, there is no clear or solitary definition of successful outcome. 25 Further, the long-term benefits need to be measured well beyond the expiry of the CTO in the context of chronic disease management. Some studies 18 perception of coercion [26] [27] [28] and the impact on the therapeutic alliance and quality of life should also be examined. Because CTOs involve formal (providers) and informal (families) systems, measures of satisfaction need to involve not only the person subject to a CTO but also other stakeholders.
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Résumé : Les ordonnances de traitement communautaire à Toronto : les nouvelles données
Objectif : Sur une période de plus de 4 ans à Toronto, cette étude a comparé les variables sociodémographiques et cliniques, l'utilisation des hôpitaux, et la continuité de l'engagement auprès des services de santé lors de la sortie du programme de prise en charge des cas entre les personnes détenant une ordonnance de traitement communautaire (OTC) et celles qui n'ont pas d'OTC. Les réductions des séjours à l'hôpital depuis la pré-admission au programme jusqu'à diverses périodes de post-admission ont été comparées dans les 2 groupes.
Méthodes : Les statistiques descriptives et la signification statistique (chi-carré et test t) ont été effectuées à partir de données administratives recueillies régulièrement pour les deux groupes.
Résultats : L'analyse catégorique des données a indiqué que les 2 groupes étaient statistiquement semblables dans une série de variables sociodémographiques et cliniques. Même si les 2 groupes démontraient des réductions de l'utilisation des hôpitaux, le groupe des OTC affichait une réduction significativement plus élevée des jours cumulatifs à l'hôpital par hospitalisation, dans la première et la deuxième période de 6 mois post-admission. Ce même groupe avait aussi une réduction significativement plus considérable des hospitalisations durant la deuxième période de 6 mois post-admission. Le groupe des OTC avait aussi une portion significativement plus élevée de personnes qui quittaient le programme durant ces 2 premières périodes de 6 mois, qui étaient moins susceptibles de quitter avec un soutien comme la prise en charge de cas ou l'ACT, et plus susceptibles de poursuivre la supervision médicale continue que le groupe de comparaison.
Conclusion :
Bien qu'il soit impossible d'éliminer la régression vers la moyenne pour les réductions d'hospitalisations, l'expérience de Toronto a démontré que les OTC sont utiles pour aider les personnes qui historiquement, refusaient les services, à rester engagés auprès des services de soutien des traitements. L'étude demande aussi un élargissement des mesures opérationnelles des résultats pour les études sur les OTC.
